A novel agent called motexafin gadolinium (MGd), with a marketed name of Xcytrin, has been studied as a potential neuroprotectant as well as...

We'll cover the general management principles for the more typical situation of patients with multiple brain metastases from lung cancer soon, but...

There is still plenty of active debate about whether patients with stage III NSCLC who have mediastinal lymph nodes, the ones in the middle of the...

I recently wrote a post about combining chemo and radiation after surgery for unsuspected stage IIIA N2 node-positive NSCLC (if discovered prior to...

Adjuvant chemo has become increasingly established as having a survival advantage, at least for the general population of stage II and IIIA patients...